Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
RV4620A + RP2552 is a dermo-cosmetic broad-spectrum SPF50+ sunscreen formulation evaluated in observational clinical studies for in-use tolerance, cosmetic acceptability, and effects on skin barrier function in adults and children with mild atopic dermatitis.[4][2][6][5] The product is described as a very high protection sunscreen for face and body, intended for subjects with sensitive, reactive skin, including those exposed to irritative factors such as chlorine, sand, salt, and sweat.[4][2] Clinical assessments focus on dermatological and pediatric tolerance, user satisfaction, and instrumental measures of transepidermal water loss, skin pH, and sebum excretion to characterize its impact on the skin barrier, but specific active UV filter ingredients and mechanistic targets are not disclosed in the available trial records.[4][2]
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on RV4620A + RP2552.